Capecitabine as NeoAdjuvant Therapy in Locally Advanced Breast Cancer
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: Capecitabine
Sponsor: University of Chicago
Collaborators: Breast Cancer Research Foundation|Roche Pharma AG